Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025

Core Viewpoint - Spero Therapeutics, Inc. is set to report its third quarter 2025 financial results and provide a business update on November 13, 2025, after market close, and will not host a conference call [1]. Company Overview - Spero Therapeutics is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections with significant unmet medical needs [2].